Atrial fibrillation during chemotherapy - Assessing the risk-benefit ratio for anticoagulation
17 March 2019 (17:37 - 18:00)
Organised by:
Slides
About the speaker
Uppsala University, Uppsala (Sweden)
3 More presentations in this session
Professor C. Sticherling (Basel, CH)
Doctor A. Lyon (London, GB)
Access the full session
The Event
EHRA 2019
17 March 2019
17:37 CET
You may be interested in
Congress Session
26 August 2023
Congress Session
13 December 2025
Congress Session
Webinar
